Selective Internal Radiation Therapy for Liver Malignancies

Summary

Selective internal radiation therapy (SIRT), also known as transarterial radioembolization, delivers high‐dose beta radiation directly to liver tumours via Yttrium-90–loaded microspheres. Following hepatic artery catheterisation, embolic microspheres lodge preferentially in the tumour microvasculature, maximising lethal irradiation to malignant cells while preserving surrounding parenchyma. Initially applied in unresectable hepatocellular carcinoma, SIRT has since expanded to intrahepatic cholangiocarcinoma and metastatic lesions from colorectal, neuroendocrine and breast cancers. Advances in pretreatment angiography, personalised dosimetry and multidisciplinary case selection have refined safety and efficacy. Key advantages include outpatient administration, lower systemic toxicity compared with conventional chemotherapy, and potential synergy with systemic agents and immunotherapies. Current research focuses on optimising radiation segmentectomy, lobar treatments and combining SIRT with targeted agents to enhance local control and overall survival.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Selective Internal Radiation Therapy for Liver Malignancies publication trend

The graph below shows the total number of articles in selective internal radiation therapy for liver malignancies across all publications each year (not limited to Nature Index journals).

Technical terms

Selective internal radiation therapy (SIRT): A locoregional cancer treatment delivering Y-90–loaded microspheres via the hepatic artery to irradiate liver tumours from within.

Yttrium-90 microspheres: Biocompatible resin or glass beads impregnated with the beta-emitter Y-90 for targeted internal radiotherapy.

Transarterial chemoembolization (TACE): A procedure combining arterial delivery of chemotherapeutic agents with embolic particles to induce ischaemia and cytotoxicity in liver tumours.

mRECIST criteria: Modified Response Evaluation Criteria in Solid Tumours adapted to quantify viable tumour response in hepatocellular carcinoma after locoregional therapies.

References

  1. A bibliometric analysis of 30 years of research on transarterial radioembolization (TARE) for hepatocellular carcinoma. Frontiers in Pharmacology (2025).
  2. Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization. Pharmaceuticals (2023).
  3. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT). CardioVascular and Interventional Radiology (2020).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.